<DOC>
	<DOCNO>NCT01624012</DOCNO>
	<brief_summary>The purpose study compare new noninvasive ventilation mode ( NIV NAVA ) well noninvasive ventilation premature infant currently use Nasal Continuous Airway Pressure ( ncpap ) , NIV NAVA give real benefit patient . The investigator study hypothesis NIV NAVA invasive ventilation synchronous patient , lead decrease need inspire oxygen .</brief_summary>
	<brief_title>Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist Versus Nasal Continuous Airway Pressure Premature Infants</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<criteria>postconceptional age 28+0 36+6 need ncpap treatment inspire oxygen least 60 minute severe birth asphyxia , malformation chromosomal abnormality , condition , decrease life expectancy condition prevents insertion naso/orogastric tube</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>48 Hours</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>NIV NAVA</keyword>
	<keyword>non-invasive ventilation</keyword>
</DOC>